Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Turk J Vasc Surg. 2021; 30(1): 35-41


The use of CO2 angiography in the treatment of peripheral arterial disease: Our initial experience

Görkem Yiğit, Anıl Özen, Metin Yılmaz, Naim Boran Tümer, Ferit Çetinkaya, Ertekin Utku Ünal, Hakkı Zafer İşcan.




Abstract

Objectives: In this study, we present our initial experience in the use of carbon dioxide (CO2) digital subtraction angiography (DSA) for
the treatment of peripheral arterial disease.
Patients and methods: This retrospective study included a total of six male patients (mean age 63.5±6.9 years; range, 56 to 72 years) with
Rutherford Stage 3-4 who were high-risk for chronic renal failure and underwent percutaneous transluminal angioplasty (PTA) due to
iliac or femoropopliteal lesions using CO2-DSA between October 2018 and January 2020. Demographic and clinical characteristics of the
patients, ankle-brachial index (ABI) values, and technical success rate were evaluated.
Results: No contrast medium was used in any of the procedure. Technical success rate was 100% and no intraoperative complication was
observed. All patients had a non-significant increase in the creatinine levels during follow-up (p=0.076). There was a significant difference
between the pre- and postoperative ABI values (p=0.028). All patients were followed in the wards after the procedure and were discharged
on postoperative Day 1 with symptomatic recovery.
Conclusion: Our study results show that CO2-DSA can be used as an affordable and effective alternative in the diagnosis and treatment of
peripheral arterial disease with contraindications for iodinated contrast material.

Key words: Angiography, carbon dioxide, contrast-induced nephropathy endovascular procedure, peripheral arterial disease






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.